McKesson Europe AG (HAM:CLS1) Debt-to-Equity : 0.07 (As of Mar. 2022)

View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG Debt-to-Equity?

McKesson Europe AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €32 Mil. McKesson Europe AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €152 Mil. McKesson Europe AG's Total Stockholders Equity for the quarter that ended in Mar. 2022 was €2,493 Mil. McKesson Europe AG's debt to equity for the quarter that ended in Mar. 2022 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for McKesson Europe AG's Debt-to-Equity or its related term are showing as below:

HAM:CLS1's Debt-to-Equity is not ranked ^*
in the Medical Distribution industry.
Industry Median: 0.29
* Ranked among companies with meaningful Debt-to-Equity only.

McKesson Europe AG Debt-to-Equity Historical Data

The historical data trend for McKesson Europe AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Debt-to-Equity Chart

McKesson Europe AG Annual Data

Trend

Dec12

Dec13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.34

0.29

0.07

McKesson Europe AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.34	0.29	0.07

Competitive Comparison of McKesson Europe AG's Debt-to-Equity

For the Medical Distribution subindustry, McKesson Europe AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

McKesson Europe AG's Debt-to-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Debt-to-Equity falls into.

McKesson Europe AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

McKesson Europe AG's Debt to Equity Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.5	+	152.4)	/	2492.6
	=	0.07

McKesson Europe AG's Debt to Equity Ratio for the quarter that ended in Mar. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.5	+	152.4)	/	2492.6
	=	0.07

McKesson Europe AG (HAM:CLS1) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

McKesson Europe AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson Europe AG (HAM:CLS1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Stockholmer Platz 1, Stuttgart, BW, DEU, 70137

Website

https://www.mckesson.eu

McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines